Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Helping Behavior × Injections × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Advanced Solid Tumor 13 Leukemia, Myeloid, Acute 10 Breast Neoplasms 6 Solid Tumor 5 Pancreatic Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Triple Negative Breast Neoplasms 4 Advanced Solid Tumors 4 Neoplasm Metastasis 3 Myelodysplastic Syndromes 3 Melanoma 3 Lung Neoplasms 3 Leukemia, Biphenotypic, Acute 3 Biliary Tract Neoplasms 3 Advanced Malignant Solid Tumor 3 Advanced Lung Cancer 3 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Solid Tumors 2 Small Cell Lung Carcinoma 2 Recurrence 2 Prostatic Neoplasms 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Ovarian Neoplasms 2 Neoplasms 2 Myelodysplastic-Myeloproliferative Diseases 2 Lymphoma, Non-Hodgkin 2 Lymphoma, B-Cell 2 Liver Neoplasms 2

Interventions

Triptorelin Pamoate 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04616729 2023-05-18

Depo-Trigger

Universitair Ziekenhuis Brussel

Phase 1/2 Unknown

Helping Behavior

Data powered by HemOnc (CC BY 4.0) Colophon ⚡